Cardiovascular risk factors and collateral artery formation.
Arterial lumen narrowing and vascular occlusion is the actual cause of morbidity and mortality in atherosclerotic disease. Collateral artery formation (arteriogenesis) refers to an active remodelling of non-functional vascular anastomoses to functional collateral arteries, capable to bypass the site of obstruction and preserve the tissue that is jeopardized by ischaemia. Hemodynamic forces such as shear stress and wall stress play a pivotal role in collateral artery formation, accompanied by the expression of various cytokines and invasion of circulating leucocytes. Arteriogenesis hence represents an important compensatory mechanism for atherosclerotic vessel occlusion. As arteriogenesis mostly occurs when lumen narrowing by atherosclerotic plaques takes place, presence of cardiovascular risk factors (e.g. hypertension, hypercholesterolaemia and diabetes) is highly likely. Risk factors for atherosclerotic disease affect collateral artery growth directly and indirectly by altering hemodynamic forces or influencing cellular function and proliferation. Adequate collateralization varies significantly among atherosclerotic patients, some profit from the presence of extensive collateral networks, whereas others do not. Cardiovascular risk factors could increase the risk of adverse cardiovascular events in certain patients because of the reduced protection through an alternative vascular network. Likewise, drugs primarily thought to control cardiovascular risk factors might contribute or counteract collateral artery growth. This review summarizes current knowledge on the influence of cardiovascular risk factors and the effects of cardiovascular medication on the development of collateral vessels in experimental and clinical studies.
Laboratory of Experimental Cardiology, UMC Utrecht, the Netherlands.
D
D
de Groot
G
G
Pasterkamp
I E
IE
Hoefer
D000367:Age Factors; D000959:Antihypertensive Agents / Q000494:pharmacology; D001158:Arteries / Q000187:drug effects / Q000254:growth & development*; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000503:physiopathology*; D003097:Collateral Circulation / Q000187:drug effects; D006801:Humans; D006937:Hypercholesterolemia; D006943:Hyperglycemia; D006973:Hypertension / Q000188:drug therapy; D018919:Neovascularization, Physiologic / Q000187:drug effects; D009765:Obesity; D012307:Risk Factors; D012907:Smoking
D000959:Antihypertensive Agents